Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor activity-modifying protein 1 (RAMP1) is a single-transmembrane-domain accessory protein that modulates the function, trafficking, and ligand specificity of certain G protein-coupled receptors (GPCRs), most notably the calcitonin receptor-like receptor (CALCRL). When associated with CALCRL, RAMP1 enables the formation of a functional receptor for calcitonin gene-related peptide (CGRP). RAMP1 plays roles in angiogenesis, lymphangiogenesis, and wound healing and represents a targetable interface for selective drugs affecting neuropeptide signaling.
Modulation of GPCR function and trafficking through direct interaction. Acts as a chaperone to get CALCRL to the cell surface and alters ligand binding properties of receptors. Targeting RAMP1, or the interface of RAMP1 and its GPCR partners, disrupts downstream signaling pathways, such as those mediated by CGRP.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor Activity-Modifying Protein 1 (RAMP1).